Analyst Evan Wilson works at MORGAN STANLEY and is focused on Communication Services, Healthcare sectors with 69 price targets and ratings documented since 2013 spanning on 5 stocks. Previously, Evan Wilson worked at KEYBANK. Analyst's average stock valuation to be materialised ratio is 85.56% with an average time for price targets to be met of 393.6 days.
Most recent stock forecast was given on ZTS, Zoetis Inc at 15-Nov-2022.
Evan Wilson best performing recommendations are on CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC) at 4/11/2019. The price target of $135 was fulfilled within 6 days with a profit of $9.21 (6.39%) receiving and performance score of 10.64.
Average potential price target upside
Currently, out of the existing stock ratings of Evan Wilson - 3034 which are a Buy (94.99%), 160 which are a Hold (5.01%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
91
$6.65 (7.88%)
88
2 days ago
4/8 (50%)
$7.18 (8.92%)
18
Hold
90
$5.65 (6.70%)
83
1 months 13 days ago
4/10 (40%)
$16.45 (21.69%)
102
Hold
90
$5.65 (6.70%)
1 months 13 days ago
4/9 (44.44%)
$15.6 (21.03%)
89
Hold
81
$-3.35 (-3.97%)
95
4 months 1 days ago
20/23 (86.96%)
$8.85 (14.04%)
171
Hold
95
$10.65 (12.63%)
95
4 months 1 days ago
10/13 (76.92%)
$14.22 (32.43%)
303
